Mifepristone Versus Misoprostol for Cervical Preparation Prior to Surgical

Status Recruiting

Clinical Trial Summary

Surgical abortion in the late first trimester and early second trimester is usually performed with the aid of a cervical preparing agent, which helps to open up the uterine cervix for the procedure. Routine use of cervical preparants is recommended by several organizations during this period of pregnancy before surgical abortion, especially in younger women or those who have not delivered a baby, because their cervices may be more difficult to dilate without a preparant.

The standard medication used for cervical preparation is misoprostol. Unfortunately, misoprostol may cause uncomfortable uterine cramping and vaginal bleeding in patients who use it. Another medication called mifepristone has been shown to dilate the cervix better than misoprostol in the first trimester, but little information exists about using mifepristone in the late first trimester and early second trimester.

The investigators plan to perform a prospective, double-blind, randomized trial to evaluate if mifepristone is a better cervical preparant than misoprostol. A total of 110 participants who are pregnant women desiring pregnancy termination 11 to 15 weeks gestational age will be recruited. Half will receive mifepristone and the other half misoprostol. The investigators will measure the amount of cervical dilation achieved right before a surgical abortion to determine if mifepristone is significantly different than misoprostol as a cervical preparant at this stage of pregnancy. The investigators expect that mifepristone will work better than misoprostol for this purpose.

The investigators hope to generate information about mifepristone so that women and their health care providers can know more about mifepristone as an option for cervical preparation before surgical abortion.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01636063
Study type	Interventional
Source	Boston University
Contact	Principal Investigator
Phone	617-414-7310
Email	fpresearch@bmc.org
Status	Recruiting
Phase	N/A
Start date	June 2012

View Details

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT02208596` - The Feasibility of Different Doses of Etomidate Admixed With Propofol in Induced Abortion: A Randomized, Double Blind Controlled Trial	Phase 4
Completed	`NCT02412618` - Same-Day Mifepristone-Misoprostol Compared to Misoprostol Only for Surgical Abortion Cervical Preparation	Phase 4
Completed	`NCT01842100` - To Compare the Strategies of Universal Antibiotic Prophylaxis Versus Screen-and-treat in Reducing Infective Complications and Re-infection in Women Who Undergo Termination of Pregnancy	N/A
Completed	`NCT00540748` - Is Oxytocin Given During Surgical Procedure for Abortion Before 12 Weeks of Pregnancy Useful?	N/A
Completed	`NCT03727308` - Study of Clinic-based Versus Self-use of Medical Abortion Pills
Completed	`NCT00482209` - Study of 400mcg Versus 800mcg Buccal Misoprostol Following Mifepristone 200mg for Abortion up to 63 Days Gestation	N/A
Recruiting	`NCT04242212` - Study of Clinic-based vs. Self-use of a Misoprostol-only Regimen for Induced Abortion
Completed	`NCT00621543` - Insertion of an Intrauterine Device (IUD) After Medical Abortion	N/A
Completed	`NCT01173003` - Expansion Study of a Simplified Regimen of Medical Abortion Thru 63 Last Menstrual Period (LMP) in Tunisia	N/A
Completed	`NCT05532085` - Assessment of Pain During an Abortion With Knowledge of the Predictive Factors of Pain.
Terminated	`NCT01776957` - Post Abortion IUD & Recurrent Abortion 2005-2006
Completed	`NCT01047748` - A Trial of Digoxin Before Second-Trimester Abortion	N/A
Completed	`NCT00401440` - Comparison of Two Regimens of Misoprostol for Second Trimester Medical Termination of Pregnancy	Phase 4
Completed	`NCT00619658` - The Feasibility of Simplified Telephone Follow-up After Medical Abortion	N/A
Completed	`NCT00324519` - Randomized Trial Comparing Misoprostol and Foley Bulb for Pregnancy Termination in the Second Trimester	Phase 4
Completed	`NCT04181541` - Midlevel Versus Physician-provided Medical Abortion in the Second Trimester	N/A
Completed	`NCT00286208` - Study of Sublingual Versus Oral Misoprostol Administration Following Mifepristone 200 mg for Abortion up to 63 Days Gestation	N/A
Completed	`NCT01085825` - Study of the Sensitivity of Manual vs Electric Aspiration to Detect Completed Early Abortion	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Mifepristone Versus Misoprostol for Cervical Preparation Prior to Surgical Abortion Between 11 to 15 Weeks — MIMI 11-15

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms